Skip to main content
. 2022 Aug 26;23(17):9704. doi: 10.3390/ijms23179704

Table 2.

Evaluation of the synthesized compounds for affinity against nucleoside kinases.

Compound Conc. Unit IC50 a
Human TK-1 Human TK-2 HSV-1 TK
2a µg/mL >200 >200 150 ± 15
2b µg/mL >200 93 ± 7 1.6 ± 0.1
2c µg/mL >200 >200 >200
2d µg/mL >200 >200 52 ± 28
2e µg/mL >100 >100 >100

a 50% inhibitory concentration, or compound concentration required to inhibit TK-catalyzed conversion of [3H]dThd to its 5′-monophosphate derivative.